APR 10, 2020 8:54 PM PDT

Cancer Therapy Drug Reverses Kidney Damage

WRITTEN BY: Nouran Amin

According to a study published in the journal Science Translational Medicine, a therapeutic previously used for cancer therapy has shown promising effects on reversing kidney damage in patients with systemic lupus erythematosus (SLE, or lupus).

Learn more about SLE:

"Kidney damage affects about half of the patients with lupus, sometimes leading to renal failure with a requirement for dialysis or transplantation," said Joe Craft, the Paul B. Beeson Professor of Medicine (rheumatology) and professor of immunobiology at Yale University. "Finding what causes that damage is extremely important."

SLE is an autoimmune disease caused by the individual’s immune cells attack their own tissues and kidneys can be particularly susceptible to the disease pathology resulting in lupus nephritis.

For lupus nephritis, a cell population referred to as ‘T-cells’ colonize kidney tissue triggering a decrease in oxygen and leading to tissue damage, potentially end-stage kidney disease. When researchers investigated the effects on infiltrating T-cells, they found that the T-cells express a marker known as hypoxia-inducible factor-1 (HIF-1) that is dependent on oxygen levels in the kidney. Activating HIF-1, results in the T-cells attacking the kidney tissues and furthering causing destruction of kidney function.

These findings allowed investigators to hypothesize that inhibiting HIF-1 function might increase oxygen levels and reduce the impact on kidneys. Thus, researchers used the HIF-1 blocking drug previously utilized in cancer therapy on mouse models of lupus.

"The findings suggest this therapy might be beneficial in lupus nephritis," Craft said. "Since this drug and others that block HIF-1 function have been used in humans with cancer, they could be used for treatment of patients with lupus."

Source: Science Daily

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
AUG 12, 2020
Drug Discovery & Development
Fast Tracking Drug Therapies
AUG 12, 2020
Fast Tracking Drug Therapies
Fast-tracking drugs in a safe and effective way can eventually save the lives of many from life-threatening diseases. Ne ...
AUG 24, 2020
Cell & Molecular Biology
A Shield Surrounds the Flexible SARS-CoV-2 Spike Protein
AUG 24, 2020
A Shield Surrounds the Flexible SARS-CoV-2 Spike Protein
Researchers know that the viruses including SARS-CoV-2 have a Spike protein that allows them to bind to receptors on hos ...
SEP 21, 2020
Drug Discovery & Development
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
SEP 21, 2020
WHO Endorses Clinical Trials for Herbal Medicines to Treat COVID-19
The World Health Organization has endorsed a protocol to put African herbal medicines through clinical trials as possibl ...
SEP 15, 2020
Drug Discovery & Development
How Can Genetic Data Make Informed Decisions About Drug Development?
SEP 15, 2020
How Can Genetic Data Make Informed Decisions About Drug Development?
How Can Genetic Data Make Informed Decisions About Drug Development? Scientists at the Integrative Epidemiology Unit (MR ...
OCT 01, 2020
Cancer
Understanding in vivo Metabolomics: C13 Isotope Studies
OCT 01, 2020
Understanding in vivo Metabolomics: C13 Isotope Studies
One key to understanding cancer metabolomics lies in the ability to accurately replicate the natural environment of the ...
OCT 12, 2020
Microbiology
Researchers May Have Found a Way to Cure Rotavirus Infections
OCT 12, 2020
Researchers May Have Found a Way to Cure Rotavirus Infections
Rotaviruses are very contagious. They are the most common cause of diarrhea in children and are estimated to cause about ...
Loading Comments...